Literature DB >> 15198860

Cell transplantation for Parkinson's disease.

Ben Roitberg1, Klaudia Urbaniak, Marina Emborg.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of the dopamine producing neurons projecting from the substantia nigra into the corpus striatum. Current medical therapy is limited and cannot stop or reverse the degeneration. Over the past 30 years, attempts were made to change the course of the disease by replacing the lost neurons with grafts from various sources. Recent controlled clinical trials of fetal cell transplantation for PD have had disappointing results. These events present an opportunity to examine the past developments and future direction of cell transplantation for PD. Copyright 2004 W.S. Maney and Son Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15198860     DOI: 10.1179/016164104225017604

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results.

Authors:  Oscar Arias-Carrión; Eric Murillo-Rodriguez; Man Xu; Carlos Blanco-Centurion; Rene Drucker-Colín; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

2.  Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.

Authors:  L Hunter Randy; Bing Guoying
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

Review 3.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 4.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

5.  Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson's Disease: A New Biological Therapy for Parkinson's Disease.

Authors:  Yun-Liang Wang; Xin-Shan Liu; Shan-Shan Wang; Peng Xue; Zhi-Lei Zeng; Xiao-Peng Yang; Si-Miao Zhang; Wei Zheng; Linlin Hua; Jin-Feng Li; Hai-Tao Wang; Shang Guo
Journal:  Stem Cells Int       Date:  2020-02-17       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.